ءMohammad Haeri

Hongyan Gu, Mohammad Haeri, Shuo Ni et al.

This work presents a mitosis detection method with only one vanilla Convolutional Neural Network (CNN). Our method consists of two steps: given an image, we first apply a CNN using a sliding window technique to extract patches that have mitoses; we then calculate each extracted patch's class activation map to obtain the mitosis's precise location. To increase the model performance on high-domain-variance pathology images, we train the CNN with a data augmentation pipeline, a noise-tolerant loss that copes with unlabeled images, and a multi-rounded active learning strategy. In the MIDOG 2022 challenge, our approach, with an EfficientNet-b3 CNN model, achieved an overall F1 score of 0.7323 in the preliminary test phase, and 0.6847 in the final test phase (task 1). Our approach sheds light on the broader applicability of class activation maps for object detections in pathology images.

Tengyou Xu, Haochen Yang, Xiang 'Anthony' Chen et al.

This abstract presents our solution (Team Westwood) for mitosis detection and atypical mitosis classification in the MItosis DOmain Generalization (MIDOG) 2025 challenge. For mitosis detection, we trained an nnUNetV2 for initial mitosis candidate screening with high sensitivity, followed by a random forest classifier ensembling predictions of three convolutional neural networks (CNNs): EfficientNet-b3, EfficientNet-b5, and EfficientNetV2-s. For the atypical mitosis classification, we trained another random forest classifier ensembling the predictions of three CNNs: EfficientNet-b3, EfficientNet-b5, and InceptionV3. On the preliminary test set, our solution achieved an F1 score of 0.7450 for track 1 mitosis detection, and a balanced accuracy of 0.8722 for track 2 atypical mitosis classification. On the final test set, our solution achieved an F1 score of 0.6972 for track 1 mitosis detection, and a balanced accuracy of 0.8242 for track 2 atypical mitosis classification.

Hongyan Gu, Yuan Liang, Yifan Xu et al.

Recent developments in AI have provided assisting tools to support pathologists' diagnoses. However, it remains challenging to incorporate such tools into pathologists' practice; one main concern is AI's insufficient workflow integration with medical decisions. We observed pathologists' examination and discovered that the main hindering factor to integrate AI is its incompatibility with pathologists' workflow. To bridge the gap between pathologists and AI, we developed a human-AI collaborative diagnosis tool -- xPath -- that shares a similar examination process to that of pathologists, which can improve AI's integration into their routine examination. The viability of xPath is confirmed by a technical evaluation and work sessions with twelve medical professionals in pathology. This work identifies and addresses the challenge of incorporating AI models into pathology, which can offer first-hand knowledge about how HCI researchers can work with medical professionals side-by-side to bring technological advances to medical tasks towards practical applications.